Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Ability to provide consent and comply with study procedures
• Diagnostic and Statistical Manual of Mental Disorders criteria for OUD
• Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD
• Intention to remain in the study until intervention completion.
Locations
United States
Minnesota
University of Minnesota
RECRUITING
Minneapolis
Contact Information
Primary
Calvin Cahill
cahil138@umn.edu
952-444-0137
Time Frame
Start Date: 2026-02-04
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 40
Treatments
Experimental: tDCS
All intervention sessions will use the Soterix Mini-CT Remote tDCS device
Related Therapeutic Areas
Sponsors
Leads: University of Minnesota